163 related articles for article (PubMed ID: 3374170)
41. Partial correction of defective generation of lymphokine-activated killer cells in patients with chronic myelogenous leukaemia after in vivo treatment with interferon-alpha (Wellferon).
Pawelec G; Schneider E; Ehninger G; Rehbein A; Schmidt H
Cancer Immunol Immunother; 1989; 29(1):63-6. PubMed ID: 2785001
[TBL] [Abstract][Full Text] [Related]
42. Lymphokine activated killer (LAK) cells in antibody dependent cellular cytotoxicity (ADCC) using MAb 17-1A: a combination of potential usefulness in tumor therapy.
Masucci G; Wersäll P; Nielsen J; Nielsen HK; Wigzell H; Mellstedt H
Hybridoma; 1989 Oct; 8(5):507-16. PubMed ID: 2807310
[TBL] [Abstract][Full Text] [Related]
43. Hairy-cells are not lysed by NK-cells.
Sigaux F; Chapuis F; Castaigne S; Degos L; Flandrin G; Gluckman JC
Blut; 1987 May; 54(5):319-20. PubMed ID: 3567370
[No Abstract] [Full Text] [Related]
44. Concomitant effect of 2'-deoxycoformycin on natural killer cell activity and tumour cell sensitivity to lysis in hairy cell leukaemia--discordant effects of alpha interferon.
Lahat N; Aghai E; Merchav S; Kinarty A; Sobel E; Froom P
Scand J Immunol; 1990 Aug; 32(2):205-9. PubMed ID: 2389114
[TBL] [Abstract][Full Text] [Related]
45. Phase I evaluation of combination therapy with interleukin 2 and gamma-interferon.
Weiner LM; Padavic-Shaller K; Kitson J; Watts P; Krigel RL; Litwin S
Cancer Res; 1991 Aug; 51(15):3910-8. PubMed ID: 1906779
[TBL] [Abstract][Full Text] [Related]
46. Discordant effect of interferon on natural killer activity and tumor cell sensitivity to lysis in hairy cell leukemia.
Lahat N; Aghai E; Kotler A; Kinarty A; Sobel E; Gruener N; Froom P
Blood; 1988 Apr; 71(4):1141-3. PubMed ID: 3258536
[TBL] [Abstract][Full Text] [Related]
47. Demonstration of the increase in serine esterase-positive T cells in hairy-cell leukemia patients undergoing alpha-interferon therapy.
Wagner L; Goldstone AH; Worman CP
Leukemia; 1989 May; 3(5):373-9. PubMed ID: 2497282
[TBL] [Abstract][Full Text] [Related]
48. Interferon alpha-2 for hairy cell leukemia: evidence for induction of RNA synthesis in hairy cells and failure to correlate enhancement of natural killer cells with elimination of hairy cells.
Schwarzmeier JD; Schwabe M; Prischl F; Wagner L; Lion T; Micksche M; Köller U
Eur J Haematol; 1987 Nov; 39(5):418-25. PubMed ID: 3691760
[TBL] [Abstract][Full Text] [Related]
49. An interferon resistant variant of the hairy-cell leukemic cell line, Eskol: biochemical and immunological characterization.
Ozes ON; Klein SB; Reiter Z; Taylor MW
Leuk Res; 1993 Nov; 17(11):983-90. PubMed ID: 7694002
[TBL] [Abstract][Full Text] [Related]
50. Strategy for the treatment of hairy cell leukemia.
Porzsolt F; Raghavachar A; Digel W; Raghavachar A; Bartram CR; Heimpel H
Leukemia; 1987 Apr; 1(4):334-7. PubMed ID: 3669758
[TBL] [Abstract][Full Text] [Related]
51. Lymphokine-activated cytotoxicity in peripheral blood mononuclear cells of severely immunocompromised HIV-infected patients.
Forthal DN; Landucci G; Robinson WE
Scand J Immunol; 1997 Jan; 45(1):91-5. PubMed ID: 9010505
[TBL] [Abstract][Full Text] [Related]
52. Hairy cells possess more interferon receptors than other lymphoid cell types.
Dadmarz R; Evans T; Secher D; Marshall N; Cawley JC
Leukemia; 1987 Apr; 1(4):357-61. PubMed ID: 2959825
[TBL] [Abstract][Full Text] [Related]
53. Reversible inhibition of lymphokine-activated killer cell activity by lipoxygenase-pathway inhibitors.
Sibbitt WL; Imir T; Bankhurst AD
Int J Cancer; 1986 Oct; 38(4):517-21. PubMed ID: 3019899
[TBL] [Abstract][Full Text] [Related]
54. Interleukin 2- and interferon alpha induced natural killer cell activity as a marker of progression in hairy cell leukemia.
Bigda J; Mysliwska J; Baran W; Hellmann A; Mysliwski A
Leuk Lymphoma; 1993 Mar; 9(4-5):371-6. PubMed ID: 8348073
[TBL] [Abstract][Full Text] [Related]
55. Lymphokine activated killer (LAK) cell mediated killing of human glioma: effect of pretreating glioma with various membrane modifying agents.
Jacobs SK; Parham CW; Holcomb B; Ikejiri B; Kornblith PL; Grimm EA
J Neurooncol; 1987; 5(1):5-10. PubMed ID: 3037036
[TBL] [Abstract][Full Text] [Related]
56. Lymphokine-activated killer (LAK) cells against human leukemia: augmentation of LAK-cell cytotoxicity by combinations of lymphokines or cytokines.
Teichmann JV; Ludwig WD; Seibt-Jung H; Thiel E
Haematol Blood Transfus; 1990; 33():103-9. PubMed ID: 2182408
[No Abstract] [Full Text] [Related]
57. Alpha-interferon activates the natural killer system in patients with hairy cell leukemia.
Semenzato G; Pizzolo G; Agostini C; Ambrosetti A; Zambello R; Trentin L; Luca M; Masciarelli M; Chilosi M; Vinante F
Blood; 1986 Jul; 68(1):293-6. PubMed ID: 3719101
[TBL] [Abstract][Full Text] [Related]
58. Lymphokine-activated killer (LAK) cell activity in B and T chronic lymphoid leukemia: defective LAK generation and reduced susceptibility of the leukemic cells to allogeneic and autologous LAK effectors.
Foa R; Fierro MT; Raspadori D; Bonferroni M; Cardona S; Guarini A; Tos AG; di Celle PF; Cesano A; Matera L
Blood; 1990 Oct; 76(7):1349-54. PubMed ID: 2207312
[TBL] [Abstract][Full Text] [Related]
59. An improved method for the generation of human lymphokine activated killer cells.
Yannelli JR; Thurman GB; Dickerson SG; Mrowca A; Sharp E; Oldham RK
J Immunol Methods; 1987 Jun; 100(1-2):137-45. PubMed ID: 3598194
[TBL] [Abstract][Full Text] [Related]
60. Natural killer, lymphokine-activated killer and interferon-gamma producing activities of peripheral blood- and regional lymph node-mononuclear cells in 23 cases of colorectal cancer.
Matsunaga H; Kuwahara Y; Kusugami K; Morise K; Shimokata K
Gastroenterol Jpn; 1988 Oct; 23(5):527-33. PubMed ID: 3145895
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
